Cost-utility analysis of acupotomy combined with epidural steroid injection for lumbosacral radiculopathy: analysis of randomized controlled trial.

Researchers studied whether combining acupotomy with epidural steroid injections works better than steroid injections alone for people with lumbosacral radiculopathy—a condition causing lower back and leg pain from compressed nerve roots. Acupotomy is a specialized technique that blends acupuncture with minimally invasive treatment to release tight tissues and adhesions. The study followed 50 patients (average age 62, mostly women) for 8 weeks, randomly assigning them to receive either the combination treatment or steroid injections only. Researchers tracked both health improvements and all costs, including medical expenses and lost work time. The combination therapy group showed better quality of life improvements and actually cost less overall—about $609 per patient compared to $757 for injections alone. The savings came partly from reduced indirect costs like less time off work ($243 versus $498). The combination treatment was considered "dominant," meaning it provided better results at lower cost. However, this was a small study at one medical center with short follow-up, so the findings are preliminary. The results suggest that adding acupotomy to standard steroid injection treatment may improve outcomes while reducing overall healthcare and societal costs for people suffering from nerve root pain in the lower back. If you're considering acupuncture or acupotomy for back pain, seek a licensed acupuncturist with specialized training in advanced techniques.

This randomized controlled trial (n=50) compared acupotomy combined with epidural steroid injection (ESI) versus ESI monotherapy for lumbosacral radiculopathy from a societal cost-utility perspective. Participants (mean age 62 years, 58% female) were followed for 8 weeks. The combination therapy demonstrated dominance with an incremental cost-utility ratio of -$16,314/QALY, generating 0.01 additional QALYs while reducing total costs by $147 per patient ($609 vs $757). Direct and indirect costs were both lower in the combination group, with notably reduced productivity losses ($243 vs $498). Utility values were measured using EQ-5D-5L. Study limitations include small sample size, short follow-up duration, and single-center design restricting generalizability. The mechanism proposed involves acupotomy's soft-tissue adhesiolysis complementing ESI's anti-inflammatory effects. This preliminary evidence suggests acupotomy with ESI may offer short-term clinical and economic advantages for managing lumbosacral radiculopathy, warranting larger confirmatory trials.